Theravance Biopharma (TBPH) Receivables - Net (2013 - 2019)

Theravance Biopharma (TBPH) has 7 years of Receivables - Net data on file, last reported at $87000.0 in Q3 2019.

• On a quarterly basis, Receivables - Net fell 97.12% year-over-year to $87000.0 in Q3 2019; TTM through Sep 2019 was $87000.0, a 97.12% decrease from a year earlier, with the FY2018 full-year figure at $620000.0, down 72.48% from the prior year.
• Receivables - Net for Q3 2019 stood at $87000.0, down from $111000.0 in the prior quarter.
• Over the last five years, Receivables - Net for TBPH reached as high as $3.4 million in Q2 2018 and fell as low as $87000.0 in Q3 2019.
• Historically, Receivables - Net has averaged $1.3 million across 5 years, with a median of $1.2 million in 2017.
• Across the five-year window, Receivables - Net jumped 18733.33% in 2015 and slumped 97.12% in 2019, its largest moves.
• Year by year, Receivables - Net stood at $1.9 million in 2015, then tumbled by 66.39% to $646000.0 in 2016, then surged by 248.76% to $2.3 million in 2017, then tumbled by 72.48% to $620000.0 in 2018, then sank by 85.97% to $87000.0 in 2019.
• Per Business Quant data, the three most recent Receivables - Net figures were $87000.0 in Q3 2019, $111000.0 in Q2 2019, and $113000.0 in Q1 2019.